SageView Advisory Group »

Innate Pharma shares owned by SageView Advisory Group

Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by SageView Advisory Group from 13F filings

Historical chart of SageView Advisory Group investment in Innate Pharma

Tip: Access up to 7 years of quarterly data

All positions including Innate Pharma held by SageView Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innate Pharma by SageView Advisory Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $2 1 2.00

More positions owned by SageView Advisory Group

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Extend Mkt Etf (VXF)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Ishares Tr Core Intl Aggr (IAGG)
Ishares Tr Global Reit Etf (REET)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPHY)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for SageView Advisory Group

Top funds holding Innate Pharma

Jane Street
Lion Point Capital
Old Mission Capital
Citadel Advisors
Rhumbline Advisers
GAMMA Investing
UBS Group
Farther Finance Advisors
SageView Advisory Group
Barclays

View all funds holding Innate Pharma